Literature DB >> 16720995

GDP and AGE receptors: mechanisms of peritoneal damage.

Vedat Schwenger1.   

Abstract

Long-term peritoneal dialysis (PD) is limited by morphological changes of the peritoneal membrane. Structural changes were promoted by toxicity of glucose degradation products (GDPs) which are generated during heat sterilization in peritoneal dialysis fluids (PDFs). Besides their direct toxicity GDPs promote formation of advanced glycation endproducts (AGEs). RAGE (receptor for AGE) is the best characterized signal transduction receptor for AGEs and is expressed on mesothelial cells. The effects of PDFs with different amounts of GDPs were compared on morphological changes in the peritoneal membrane in a RAGE -/- mouse model. It could be demonstrated that RAGE plays a pivotal role in structural damage (e.g. inflammation, neoangiogenesis and fibrosis) of the peritoneal membrane. Further investigations of this pathway with regard to preventing peritoneal fibrosis should be performed to maintain the integrity of the peritoneal membrane in peritoneal dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720995     DOI: 10.1159/000093505

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  6 in total

1.  Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition.

Authors:  Jeong Sup Song; Chun Mi Kang; Chan Kwon Park; Hyung Kyu Yoon; Sook Young Lee; Joong Hyun Ahn; Hwa-Sik Moon
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

2.  Neuronal damage and shortening of lifespan in C. elegans by peritoneal dialysis fluid: Protection by glyoxalase-1.

Authors:  Andrea Schlotterer; Friederike Pfisterer; Georgi Kukudov; Britta Heckmann; Daniel Henriquez; Christian Morath; Bernhard K Krämer; Hans-Peter Hammes; Vedat Schwenger; Michael Morcos
Journal:  Biomed Rep       Date:  2018-04-03

Review 3.  Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume.

Authors:  Michel Fischbach; Ariane Zaloszyc; Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2013-08-02       Impact factor: 3.714

4.  New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models.

Authors:  Mineaki Kitamura; Tomoya Nishino; Yoko Obata; Yoshiyuki Ozono; Takehiko Koji; Shigeru Kohno
Journal:  Acta Histochem Cytochem       Date:  2014-07-16       Impact factor: 1.938

5.  Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.

Authors:  Kazuya Maeda; Shigehiro Doi; Ayumu Nakashima; Takuo Nagai; Taisuke Irifuku; Toshinori Ueno; Takao Masaki
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 6.  Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience.

Authors:  Krzysztof Pawlaczyk; Ewa Baum; Krzysztof Schwermer; Krzysztof Hoppe; Bengt Lindholm; Andrzej Breborowicz
Journal:  Biomed Res Int       Date:  2015-07-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.